Dual targeting of 3CL(pro) and PL(pro) of SARS-CoV-2: A novel structure-based design approach to treat COVID-19

With the rapid growth of the COVID-19 (coronavirus disease 2019) pandemic across the globe, therapeutic attention must be directed to fight the novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). However, developing new antiviral drugs and vaccines is time-consuming, so one of the be...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajpoot, Sajjan, Alagumuthu, Manikandan, Baig, Mirza S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726703/
https://www.ncbi.nlm.nih.gov/pubmed/33319212
http://dx.doi.org/10.1016/j.crstbi.2020.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726703/
https://www.ncbi.nlm.nih.gov/pubmed/33319212
http://dx.doi.org/10.1016/j.crstbi.2020.12.001

Ejemplares similares